Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Felodipine 2.5mg modified-release / Ramipril 2.5mg tablets
0205051S0AAAAAA
|
Felodipine/ramipril | Ramipril with calcium channel blocker | Cardiovascular System | 110 |
|
Fibrazate XL 400mg tablets
0212000D0BFAAAB
|
Fibrazate | Bezafibrate | Cardiovascular System | 110 |
|
Hytrin 10mg tablets
0205040V0BBADAD
|
Hytrin | Terazosin hydrochloride | Cardiovascular System | 107 |
|
Retalzem 60 modified-release tablets
0206020C0BTAAAA
|
Retalzem | Diltiazem hydrochloride | Cardiovascular System | 107 |
|
Triamterene 50mg / Chlortalidone 50mg tablets
0202040V0AAAAAA
|
Triamterene with thiazides | Triamterene with thiazides | Cardiovascular System | 107 |
|
Adalat retard 10mg tablets
0206020R0BBAGAE
|
Adalat | Nifedipine | Cardiovascular System | 106 |
|
Clopidogrel 300mg tablets
0209000C0AAAEAE
|
Clopidogrel | Clopidogrel | Cardiovascular System | 105 |
|
Clopidogrel 25mg/5ml oral suspension
0209000C0AAADAD
|
Clopidogrel | Clopidogrel | Cardiovascular System | 104 |
|
Prazosin 5mg tablets
0205040S0AAAEAE
|
Prazosin hydrochloride | Prazosin hydrochloride | Cardiovascular System | 104 |
|
Larbex XL 4mg tablets
0205040D0BJAAAQ
|
Larbex | Doxazosin mesilate | Cardiovascular System | 103 |
|
Omega 3-acid-ethyl esters 1000mg capsules (strides)
0212000ABBLAAAA
|
Omega-3-acid-ethyl esters (Strides) | Omega-3-acid ethyl esters | Cardiovascular System | 103 |
|
Xarelto 2.5mg tablets
0208020Y0BBADAD
|
Xarelto | Rivaroxaban | Cardiovascular System | 103 |
|
Dexipress MR 20mg tablets
0206020R0CKAAAR
|
Dexipress | Nifedipine | Cardiovascular System | 101 |
|
Isoket Retard 40 tablets
0206010I0BGAGAJ
|
Isoket | Isosorbide dinitrate | Cardiovascular System | 99 |
|
Tinzaparin sodium 20,000units/2ml inj vials
0208010W0AAANAN
|
Tinzaparin sodium | Tinzaparin sodium | Cardiovascular System | 97 |
|
Teveten 300mg tablets
0205052W0BBAAAA
|
Teveten | Eprosartan | Cardiovascular System | 95 |
|
Adalat LA 20mg tablets
0206020R0BBAJAR
|
Adalat | Nifedipine | Cardiovascular System | 93 |
|
Atorvastatin 10mg/5ml oral solution
0212000B0AAAHAH
|
Atorvastatin | Atorvastatin | Cardiovascular System | 93 |
|
Chlorothiazide 250mg/5ml oral solution
0202010D0AABCBC
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | 92 |
|
Inegy 10mg/20mg tablets
0212000ACBBAAAA
|
Inegy | Simvastatin and ezetimibe | Cardiovascular System | 92 |
|
Evolocumab 140mg/1ml inj pre-filled disposable devices
0212000AHAAAAAA
|
Evolocumab | Evolocumab | Cardiovascular System | 89 |
|
Lescol XL 80mg tablets
0212000M0BBACAD
|
Lescol | Fluvastatin sodium | Cardiovascular System | 89 |
|
Sotacor 80mg tablets
0204000T0BCAAAC
|
Sotacor | Sotalol hydrochloride | Cardiovascular System | 89 |
|
Moxisylyte 40mg tablets
0206040AIAAACAC
|
Moxisylyte hydrochloride (Systemic) | Moxisylyte hydrochloride | Cardiovascular System | 88 |
|
Brilique 60mg tablets
0209000Z0BBABAB
|
Brilique | Ticagrelor | Cardiovascular System | 86 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.